Novartis AG (NVS)

75.01
0.09 0.12
NYSE : Health Care
Prev Close 75.10
Open 75.13
Day Low/High 74.99 / 75.20
52 Wk Low/High 66.93 / 83.58
Volume 399.45K
Avg Volume 3.38M
Exchange NYSE
Shares Outstanding 2.37B
Market Cap 176.56B
EPS 2.80
P/E Ratio 26.37
Div & Yield 2.75 (3.70%)

Latest News

Stocks Fall for Day Two as Trump Targets Health Care Sector

Stocks Fall for Day Two as Trump Targets Health Care Sector

Stocks fall for a second day on Tuesday, the first back-to-back decline since January, as a selloff in health care spoils attempts by the market to push higher.

Stocks Slide as Health Care Sector Weighs on Wall Street

Stocks Slide as Health Care Sector Weighs on Wall Street

Stocks slump Tuesday as a selloff in health care spoils an attempt by the market to push higher.

Drugmakers Suffer After Trump Tweet

Drugmakers Suffer After Trump Tweet

Stocks were under pressure again after Donald Trump made vague promises to lower drug prices.

Stocks Fluctuate as Wall Street Digests Health Care Moves From Washington

Stocks Fluctuate as Wall Street Digests Health Care Moves From Washington

Stocks are in flux on Tuesday as Donald Trump makes vague promises to lower drug prices, while Republicans unveil their bill to tackle health care reform.

European Health Care Stocks Wobble After Trump Tweet on Drug Prices

European Health Care Stocks Wobble After Trump Tweet on Drug Prices

European healthcare stocks fell Tuesday after President Donald Trump reiterated a vow to reduce drug prices in the United States.

Trump's Anti-Pot Stance Won't Hurt This 'Canna-Business' Stock

Trump's Anti-Pot Stance Won't Hurt This 'Canna-Business' Stock

President Trump's socially conservative administration has vowed to crack down on marijuana, but here's why pot investors shouldn't worry.

Novartis Shares Lower on Ex Dividend Trading, Reports of Kickbacks Fine In South Korea

Novartis Shares Lower on Ex Dividend Trading, Reports of Kickbacks Fine In South Korea

Novartis shares fell in Zurich Thursday after it had the sales of some of its drugs banned in South Korea following a fine from food and drug safety officials.

Kite Pharma CAR-T Cancer Therapy Shows Strong, Durable Effect in Lymphoma Patients

Kite Pharma CAR-T Cancer Therapy Shows Strong, Durable Effect in Lymphoma Patients

Kite intends to submit a marketing application for KTE-C19 to the U.S. Food and Drug Administration by the end of March.

Norway's $900 Billion Sovereign Wealth Fund Rebounds in 2016 With 8.7% Equity Surge

Norway's $900 Billion Sovereign Wealth Fund Rebounds in 2016 With 8.7% Equity Surge

Norway's sovereign wealth fund, the world's biggest and a key investor in Apple and Alphabet, earned more than $53 billion last year as equity returns surged.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Cramer: Money's Being Thrown at Almost Everything in the Market

Cramer: Money's Being Thrown at Almost Everything in the Market

There are nearly too many surging sectors to count.

Novartis Shows the World a Take of 2 Charts

Novartis Shows the World a Take of 2 Charts

Novartis has seen some very aggressive buying the past five months -- time to join in.

Ring the Register With These Upcoming Spinoffs

Ring the Register With These Upcoming Spinoffs

Numerous studies show that corporate carve outs deliver robust returns.

Bristol-Myers Buys Back Shares, Shuffles Board

Bristol-Myers Buys Back Shares, Shuffles Board

The drug company will carry out 80% of a $2B repurchase by Feb. 28 after pressure from insurgent Jana Partners. Icahn also reportedly acquired a stake, with focus on M&A.

Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial

Celgene Multiple Sclerosis Pill Succeeds in First Late-Stage Clinical Trial

Ozanimod is part of Celgene's strategy to grow its inflammation and immunology business as a diversification hedge away from Revlimid, the blockbuster blood cancer drug.

Biotech Buoyed by Deal Talk

Biotech Buoyed by Deal Talk

M&A activity is in a serious upswing, and here are some names to watch.

Propeller Health Enters Into Collaboration To Connect Breezhalerâ„¢ Devices To The Propeller Platform

Propeller Health Enters Into Collaboration To Connect Breezhalerâ„¢ Devices To The Propeller Platform

Partnership adds another important family of leading respiratory brands and solidifies Propeller's position as the leading digital platform in respiratory medicine

Cellectis Gains FDA Nod to Test New Gene-Edited Cancer Treatment

Cellectis Gains FDA Nod to Test New Gene-Edited Cancer Treatment

Cellectis is taking another step to move immunotherapy 'off the shelf.'

Mallinckrodt Divests Drug Delivery Unit as Shedding Continues

Mallinckrodt Divests Drug Delivery Unit as Shedding Continues

The pharmaceutical company has signed a deal to sell its intrathecal therapy segment to a Piramal Enterprises subsidiary for up to $203 million.

Now That Dow Has Hit 20,000, GM and Nike Are Hot Stocks

Now That Dow Has Hit 20,000, GM and Nike Are Hot Stocks

Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.

GM, Nike, Microsoft Are Hot Now That Dow Has Hit 20,000

GM, Nike, Microsoft Are Hot Now That Dow Has Hit 20,000

Some of Wall Street's biggest stocks are teetering on the edge of breakout territory this week. Here are five of them.

Dow Sets New Record After Smashing Through 20,000 Milestone

Dow Sets New Record After Smashing Through 20,000 Milestone

It finally did it. The Dow Jones Industrial Average smashed through 20,000 after hemming and hawing over the milestone.

Dow Posts Solid Gains After Crossing the 20,000 Milestone

Dow Posts Solid Gains After Crossing the 20,000 Milestone

After slaying its 20,000 milestone Wednesday morning, the Dow Jones Industrial Average extends gains through the afternoon to make a play for 20,100.

What Next as Dow Breaks Through Historic Milestone?

What Next as Dow Breaks Through Historic Milestone?

The Dow Jones Industrial Average finally pushes past the 20,000 milestone after teetering close to that level weeks earlier.

Positive Earnings Are Setting Up the Dow for Its Push to 20,000

Positive Earnings Are Setting Up the Dow for Its Push to 20,000

A series of positive earnings on Wednesday morning set the Dow Jones Industrial Average up to close in on its 20,000 milestone.

Wake Up Wall Street: Positive Earnings Drive Early Trading Higher

Wake Up Wall Street: Positive Earnings Drive Early Trading Higher

Reports from DuPont and Alibaba looked promising for the markets on Wednesday.

5 Things You Must Know Before the Market Opens Wednesday

5 Things You Must Know Before the Market Opens Wednesday

U.S. stock futures rise Wednesday and European stocks book solid gains as corporate earnings in the U.S. drive Wall Street higher.

News Out of Europe: Intesa Confirms Potential Bid for Generali

News Out of Europe: Intesa Confirms Potential Bid for Generali

News of Intesa's potential takeover bid extended Generali's three-day gains to 15%.